Patent · US Active

CRISPR/CAS-related methods and compositions for treating sickle cell disease

US11242525B2 · kind B2 · utility

0Cited by
18References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2015
Grant dateFeb 8, 2022
Priority date—
Expiry dateApr 12, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

CRISPR/CAS-related compositions and methods for treatment of Sickle Cell Disease (SCD) are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.